Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Prometheus' spirit: quality survival in advanced hepatocellular carcinoma after gemcitabine and cisplatin-based chemotherapy

< Back to Listing

Share this Article

Singapore Med J 2008; 49(10): e293-e295
Prometheus' spirit: quality survival in advanced hepatocellular carcinoma after gemcitabine and cisplatin-based chemotherapy

  • Abstract
  • PDF

Doval DC, Pande SB, Sharma JB, Pavithran K, Jena A, Vaid AK
Correspondence: Dr Dinesh C Doval, dcdoval@yahoo.com

ABSTRACT
In advanced virus-induced hepatocellular carcinoma (HCC) associated with cirrhosis, the average survival is four months. We report a 56-year-old man with a large-volume advanced HCC, in whom gemcitabine and cisplatin-based chemotherapy resulted in near-complete regression, and quality survival of 24 months.

Keywords: alpha foetoprotein, cisplatin, gemcitabine, hepatocellular carcinoma, liver cancer, liver cirrhosis
Singapore Med J 2008; 49(10): e293-e295

http://smj.org.sg/sites/default/files/4910/4910cr12.pdf
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.